Tradestie Institutional Equity Comparison Engine
COCP vs PRPO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PRPO Overall Edge
PRPO Captures Institutional Edge (2โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Precipio, Inc. Common Stock (PRPO) driven by superior Valuation, Growth & Margin while COCP counters with relative strength in Momentum & Technical. Fundamentally, COCP trades at N/M Forward P/E with -3063.6% operating margin (+26.9% YoY revenue) versus PRPO at 15.4x Forward P/E and -5.3% operating margin (+8.3% YoY). In options structure, COCP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PRPO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
PRPO
COCP N/M vs PRPO 15.4x Fwd P/E
Growth & Margin Winner
PRPO
Op Margin -3063.6% vs -5.3% ยท YoY +26.9% vs +8.3%
Momentum & Technical Winner
COCP
1Y -3.0% vs +1.9% ยท 52W Pos 19% vs 16%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
COCP
NASDAQ
Cocrystal Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+1.98% 1D
Market Cap
$19.6M
1M Return
-2.01%
1Y Return
-2.96%
Forward P/E
N/M
Unified AI Score
47.1 / 100
HOLD
Tech 51.0
Fund 48.0
Flow 50.0
Mom 54.0
PRPO
NASDAQ
Precipio, Inc. Common Stock
Laboratory Analytical Instruments
$20.39
-7.86% 1D
Market Cap
$40.2M
1M Return
-4.61%
1Y Return
+1.95%
Forward P/E
15.4x
Unified AI Score
32.2 / 100
SELL
Tech 5.0
Fund 31.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
COCP -2.96%
PRPO +1.95%
Spread: +7.42 pp (PRPO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
COCP TTM Op. Margin: -3063.6%
PRPO TTM Op. Margin: -5.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on COCP vs PRPO. Trailing 12-month operating profitability (COCP -3063.6% vs PRPO -5.3%) and valuation multiples (COCP N/M vs PRPO 15.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | COCP | PRPO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $40.2M | Larger Scale | PRPO |
| Trailing P/E Ratio Valuation | N/M | 15.4x | Lower Multiple | PRPO |
| Forward P/E Ratio Valuation | N/M | 15.4x | Lower Multiple | PRPO |
| Revenue Growth (YoY) Growth | +26.9% | +8.3% | Higher Growth | COCP |
| Operating Margin (TTM) Profitability | -3063.6% | -5.3% | Higher Margin | PRPO |
| Net Profit Margin Profitability | 0.0% | -4.1% | Higher Margin | COCP |
| Return on Equity (ROE) Capital Efficiency | -311.7% | -8.0% | Higher ROE | PRPO |
| 52-Week Range Position Momentum | 19% ($1โ$2) | 16% ($18โ$34) | Stronger Trend | COCP |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 54% Vol | 1.19ฮฒ ยท 95% Vol | Lower Realized Risk | COCP |
| Unified Institutional Score Composite Signal | 47.1 / 100 (HOLD) | 32.2 / 100 (SELL) | Higher Composite | COCP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full COCP vs PRPO Buy Guide
COCP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PRPO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither COCP nor PRPO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.